UMC Radboud

Nijmegen 6525AG

2 studies enrolling now · 5 studies all time

What they study most

Advanced/Metastatic Solid Tumors, Carcinoma, Non-Small-Cell Lung, Castration-Resistant Prostatic Neoplasms, Colorectal Cancer, Esophageal Cancer, Gastric Cancer, Gastroesophageal-junction Cancer, HNSCC, Head and Neck Squamous Cell Carcinoma, Hemostasis, Hemostatic Techniques, Multiple Myeloma

Studies at this site

• A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open Surgery — Recruiting now
• A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors — Recruiting now
• A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Running, not enrolling
• A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy — Running, not enrolling
• A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer — Completed